EDGAR Filing Documents for 0001279569-12-001227

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-12-001227

Filing Date

2012-10-18

Accepted

2012-10-18 16:28:03

Documents

Period of Report

2012-10-18

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v325923_6k.htm	6-K	11865
2	Q1 INTERIM FINANCIAL STATEMENTS	v325923_ex99-1.htm	EX-99.1	247445
3	Q1 MANAGEMENTS DISCUSSION AND ANALYSIS	v325923_ex99-2.htm	EX-99.2	122066
4	CEO/CFO CERTIFICATES	v325923_ex99-3.htm	EX-99.3	19858
	Complete submission text file	0001279569-12-001227.txt		402456

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 121150679
SIC: 2836 Biological Products, (No Diagnostic Substances)